Treatment of multidrug-resistant tuberculosis in Taiwan

Jen Suo, Ming Chih Yu, Chun Nin Lee, Chen Yuan Chiang, Tao Pin Lin

研究成果: 雜誌貢獻文章

22 引文 斯高帕斯(Scopus)

摘要

Eighty-seven patients with multidrug-resistant tuberculosis (MDR-TB) diagnosed between 1988 and 1990 were treated with isoniazid and at least three other effective second-line drugs based on in vitro susceptibility tests. Of these patients, 10% failed to adhere to the regimen and 43% remained sputum positive after 6 months of treatment. Only 47% showed sputum conversion within 6 months of treatment and 12% of them relapsed during the first year of follow-up. From September 1987 to July 1989, 36 patients with MDR-TB were treated with a regimen containing rifabutin, isoniazid and at least three other susceptible drugs. Only 47% achieved a sustained sputum conversion. Four died during treatment due to disease progression. From March 1992 to July 1993, 17 cases of MDR-TB were treated with an ofloxacin-containing anti-TB regimen for 12-24 months. Two failed to adhere to the regimen for more than 1 month during the first 6 months of therapy. Among the remaining 15, 26% failed to achieve sputum conversion, 73% achieved bacterial conversion, 9 within 1 month and the other 2 within 2 months. No significant adverse effect was associated with ofloxacin use. We concluded that ofloxacin is a better choice among the more toxic and less potent second-line drugs, and should be used along with other anti-TB drugs in treating patients with MDR-TB.

原文英語
頁(從 - 到)20-23
頁數4
期刊Chemotherapy
42
發行號SUPPL. 3
出版狀態已發佈 - 十二月 1996
對外發佈Yes

ASJC Scopus subject areas

  • Pharmacology (medical)

指紋 深入研究「Treatment of multidrug-resistant tuberculosis in Taiwan」主題。共同形成了獨特的指紋。

  • 引用此

    Suo, J., Yu, M. C., Lee, C. N., Chiang, C. Y., & Lin, T. P. (1996). Treatment of multidrug-resistant tuberculosis in Taiwan. Chemotherapy, 42(SUPPL. 3), 20-23.